Before symptoms.
Before spread.
The future of cancer care starts earlier.
PreOncology is pioneering the future of cancer care—detecting and preventing cancer before symptoms appear, before tumors form, and before it’s too late. By combining AI, genetics, liquid biopsy, and whole-body MRI, we identify cancer at its earliest, most curable stage: Stage Alpha.


What is Stage Alpha?
Stage Alpha is the earliest, preclinical phase of cancer—when biological changes have begun, but before tumors are visible to standard imaging techniques, or symptoms arise. It's the moment when cancer is most curable, yet most often missed.
​
At PreOncology, we use advanced tools like ctDNA analysis, whole-body MRI with Radiomics, and AI-driven multiomic modeling to detect Stage Alpha. By finding cancer this early, we unlock the chance to treat it before it grows, spreads, or even forms a tumor. It’s not just ultra early detection—its prevention made personal.
About Us
Our Mission & Vision
We are board certified Oncologists pioneering a new medical subspecialty—PreOncology—focused on detecting and preventing cancer at its earliest, most curable stage. We empower patients and providers with personalized risk scores, AI-driven insights, and cutting-edge diagnostics that shift cancer care from late-stage reaction to proactive prevention.
​
​We envision a future where cancer is prevented or intercepted before it becomes visible or symptomatic. A Multi-Omics platform that integrates AI, genetics, liquid biopsy, and whole-body MRI into a unified platform, we aim to make Stage Alpha detection a standard part of health care—giving people more time, more options, and more peace of mind.
Our Company
PreOncology is backed by Oncoled Ventures, a physician-led venture fund supported by U.S. oncologists. This foundation ensures that our work is both scientifically rigorous and deeply connected to the realities of cancer care.
1. Mission Alignment – Our work is physician-driven, with the potential to translate quickly to meaningful patient outcomes.
2. Clinical Relevance –We have strong ties to the real-world cancer community.
3. Financial Responsibility – We have the resources to support patient centered long-term projects.
Meet the Team
Meet the core team pioneering PreOncology—a group of innovators, clinicians, and design leaders committed to redefining cancer care through ultra-early detection and prevention.






